Thomas C. Mckenzie

Array ( [id] => 6952902 [patent_doc_number] => 20050227997 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-13 [patent_title] => 'Selective inhibition of aggrecanase in osteoarthritis treatment' [patent_app_type] => utility [patent_app_number] => 11/120376 [patent_app_country] => US [patent_app_date] => 2005-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27381 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20050227997.pdf [firstpage_image] =>[orig_patent_app_number] => 11120376 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6957879 [patent_doc_number] => 20050214249 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'O2-substituted 1-[(2-carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolates' [patent_app_type] => utility [patent_app_number] => 11/104232 [patent_app_country] => US [patent_app_date] => 2005-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 20775 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20050214249.pdf [firstpage_image] =>[orig_patent_app_number] => 11104232 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 645733 [patent_doc_number] => 07119199 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-10 [patent_title] => 'Process for the preparation of pyridopyrimidones' [patent_app_type] => utility [patent_app_number] => 11/029139 [patent_app_country] => US [patent_app_date] => 2004-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1977 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/119/07119199.pdf [firstpage_image] =>[orig_patent_app_number] => 11029139 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6991463 [patent_doc_number] => 20050090500 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => 'Stable polymorph of N-(3-ethynylphenyl)-6, 7-bis (2-methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof' [patent_app_type] => utility [patent_app_number] => 10/992266 [patent_app_country] => US [patent_app_date] => 2004-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13468 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20050090500.pdf [firstpage_image] =>[orig_patent_app_number] => 10992266 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 655279 [patent_doc_number] => 07109332 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-09-19 [patent_title] => '2,4-dioxo-3-quinazolinylaryl sulfonylureas' [patent_app_type] => utility [patent_app_number] => 10/956004 [patent_app_country] => US [patent_app_date] => 2004-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13533 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/109/07109332.pdf [firstpage_image] =>[orig_patent_app_number] => 10956004 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7127925 [patent_doc_number] => 20050059669 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'M-substituted benzoic acid derivatives having integrin alpha v beta 3 antagonistic activity' [patent_app_type] => utility [patent_app_number] => 10/944712 [patent_app_country] => US [patent_app_date] => 2004-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53151 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20050059669.pdf [firstpage_image] =>[orig_patent_app_number] => 10944712 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 531823 [patent_doc_number] => 07179805 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-20 [patent_title] => '7-amino alkylidenyl-heterocyclic quinolones and naphthyridones' [patent_app_type] => utility [patent_app_number] => 10/937238 [patent_app_country] => US [patent_app_date] => 2004-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18131 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/179/07179805.pdf [firstpage_image] =>[orig_patent_app_number] => 10937238 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7163201 [patent_doc_number] => 20050085447 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-21 [patent_title] => 'Pyrido[3,4-d]pyrimidine derivatives as matrix metalloproteinase-13 inhibitors' [patent_app_type] => utility [patent_app_number] => 10/921055 [patent_app_country] => US [patent_app_date] => 2004-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 48180 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20050085447.pdf [firstpage_image] =>[orig_patent_app_number] => 10921055 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 695888 [patent_doc_number] => 07071333 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-07-04 [patent_title] => 'Triazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same' [patent_app_type] => utility [patent_app_number] => 10/901677 [patent_app_country] => US [patent_app_date] => 2004-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14318 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/071/07071333.pdf [firstpage_image] =>[orig_patent_app_number] => 10901677 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7378491 [patent_doc_number] => 20040220193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => 'Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound' [patent_app_type] => new [patent_app_number] => 10/855357 [patent_app_country] => US [patent_app_date] => 2004-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 79452 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20040220193.pdf [firstpage_image] =>[orig_patent_app_number] => 10855357 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7255449 [patent_doc_number] => 20050075353 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-07 [patent_title] => 'Quinazolines and therapeutic use thereof' [patent_app_type] => utility [patent_app_number] => 10/852076 [patent_app_country] => US [patent_app_date] => 2004-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 20028 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20050075353.pdf [firstpage_image] =>[orig_patent_app_number] => 10852076 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 750926 [patent_doc_number] => 07022850 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-04 [patent_title] => 'Bicyclicpyrimidones and their use to treat diseases' [patent_app_type] => utility [patent_app_number] => 10/848089 [patent_app_country] => US [patent_app_date] => 2004-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19243 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/022/07022850.pdf [firstpage_image] =>[orig_patent_app_number] => 10848089 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 699739 [patent_doc_number] => 07067659 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-27 [patent_title] => 'Reactive oxygen generating enzyme inhibitor with nitric oxide bioactivity and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/829940 [patent_app_country] => US [patent_app_date] => 2004-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 3202 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/067/07067659.pdf [firstpage_image] =>[orig_patent_app_number] => 10829940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7378380 [patent_doc_number] => 20040220186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => 'PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease' [patent_app_type] => new [patent_app_number] => 10/828485 [patent_app_country] => US [patent_app_date] => 2004-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18570 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20040220186.pdf [firstpage_image] =>[orig_patent_app_number] => 10828485 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7239232 [patent_doc_number] => 20040157863 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-12 [patent_title] => 'Triazolopyrimidines' [patent_app_type] => new [patent_app_number] => 10/474948 [patent_app_country] => US [patent_app_date] => 2004-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23356 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20040157863.pdf [firstpage_image] =>[orig_patent_app_number] => 10474948 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7190754 [patent_doc_number] => 20040204427 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-14 [patent_title] => 'Pyrimido compounds having antiproliferative activity' [patent_app_type] => new [patent_app_number] => 10/817697 [patent_app_country] => US [patent_app_date] => 2004-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32655 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20040204427.pdf [firstpage_image] =>[orig_patent_app_number] => 10817697 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7351903 [patent_doc_number] => 20040248904 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'New piperidinylamino-thieno[2,3-d] pyrimidine compounds' [patent_app_type] => new [patent_app_number] => 10/815417 [patent_app_country] => US [patent_app_date] => 2004-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25423 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20040248904.pdf [firstpage_image] =>[orig_patent_app_number] => 10815417 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7468798 [patent_doc_number] => 20040167158 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-26 [patent_title] => 'Heterocyclic compounds for the treatment of migraine' [patent_app_type] => new [patent_app_number] => 10/784673 [patent_app_country] => US [patent_app_date] => 2004-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17132 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20040167158.pdf [firstpage_image] =>[orig_patent_app_number] => 10784673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 645751 [patent_doc_number] => 07119200 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-10 [patent_title] => 'Pyrazolopyrimidines as cyclin dependent kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/776988 [patent_app_country] => US [patent_app_date] => 2004-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 66402 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/119/07119200.pdf [firstpage_image] =>[orig_patent_app_number] => 10776988 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7239618 [patent_doc_number] => 20040157896 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-12 [patent_title] => 'Methods for treating neurodegenerative disorders using aspartyl protease inhibitors' [patent_app_type] => new [patent_app_number] => 10/774262 [patent_app_country] => US [patent_app_date] => 2004-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 18615 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20040157896.pdf [firstpage_image] =>[orig_patent_app_number] => 10774262 [rel_patent_id] =>[rel_patent_doc_number] =>)